Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 1 29Phase 3 17Phase 1/2 7Phase NA 2Phase EARLY_PHASE1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 19Other hematologic neoplasm 17Myeloid 8Plasma cell 7Dermatologic 6Sarcoma 5Classical hematology 3CNS 2Breast 2Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Neuroblastoma 1Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 52Radiosurgery 38Radiotherapy 24Blood Specimen Collection 21Magnetic Resonance Imaging 17Bevacizumab 16Temozolomide 13Radiation 12Proton Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Mental Status and Dementia Tests 9Carboplatin 9Surgical Procedures, Operative 8Exercise 8Dexmedetomidine 8Vincristine 7Surveys and Questionnaires 7Spinal Puncture 7Etoposide 7Drug Therapy 7Biopsy 7Saline Solution 6Diffusion Tensor Imaging 6Dexamethasone 6Cyclophosphamide 6Therapeutics 5Standard of Care 5Restraint, Physical 5Propofol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Filgrastim × CNS × Clear all
NCT00416819 2015-08-20

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

University of California, San Francisco

Phase NA Completed
10 enrolled
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

NCT00526318 2015-07-16

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
360 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡